Gilteritinib Fumarate and its Impurities

Gilteritinib Fumarate, sold under the brand name Xospata, is an anti-cancer drug. It acts as an inhibitor of FLT3, hence it is a tyrosine kinase inhibitor.Gilteritinib has been repurposed as a potential antiviral drug as a possible application in the treatment of COVID-19. Reference standards of Gilteritinib Fumarate API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.